Compare Omnicom Group Inc. (OMC) vs Tilray Brands Inc (TLRY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Omnicom Group Inc. vs Tilray Brands Inc — how do they compare? Omnicom Group Inc. trades at $78.55 (market cap $22.26B), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: Omnicom Group Inc. is far larger — about 37.6× Tilray Brands Inc's market cap, and Omnicom Group Inc. pays a 3.94% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.
| OMC | TLRY | |
|---|---|---|
Market Cap | $22.26B | $591.60M |
Sector | Media | Health |
52-Week High | $88.94 | $21.00 |
52-Week Low | $67.27 | $3.88 |
Enterprise Value | $30.33B | $758.73M |
Dividend Yield | 3.94% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Omnicom Group (OMC) trades at $81.13, down 1.8% on the day, amid a bearish technical signal. The stock shows mixed fundamentals with a high P/E of 219.27 but attractive P/S of 0.91, while 2025 net income turned negative. Recent leadership changes and media agency launches signal strategic shifts. Analyst consensus is a 'Hold' with a $96.50 price target, implying potential upside from current levels.
The outlook hinges on execution of post-merger synergies and organic growth recovery. Risks include integration costs and competitive pressures, but the 4% dividend yield and undervaluation relative to sales offer a margin of safety. Earnings consistency remains key for sustained appreciation.
TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.
TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Omnicom Group Inc.
Omnicom is the world's second- largest ad holding company, based on annual revenue. The firm's services, which include traditional and digital advertising and public relations, are provided worldwide, with over 85% of its revenue coming from more developed regions such as North America and Europe.
Read more on OMC →About Tilray Brands Inc
Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →
